Jynarque
Ended Awarded Last action
- Contract number
- 36C24620N1004
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $10,035 |
About this award
On June 5, 2020, the Department of Veterans Affairs, specifically Veterans Integrated Service Network 6 (VISN 6), awarded a $10,034.63 delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan), a specialty pharmaceutical medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract was awarded on a firm-fixed price basis without set-aside designation and was delivered to a location in Potomac, Maryland, with an ultimate completion date of June 16, 2020. This delivery order represents a task order issued under Otsuka America's larger Federal Supply Schedule contract for pharmaceuticals.
This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and draws from Otsuka America's substantial Indefinite Delivery Vehicle portfolio with the VA, which includes an $83.3 million Blanket Purchase Agreement for Jynarque and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. These IDVs enable VA facilities across multiple Integrated Service Networks to efficiently procure critical pharmaceutical treatments for veterans. As a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America has established itself as a key supplier of specialty pharmaceuticals to the Department of Veterans Affairs' healthcare system.
Quick answers
Who was awarded contract 36C24620N1004?
36C24620N1004 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on June 5, 2020.
How much is contract 36C24620N1004 worth?
The government has obligated $10,035 on 36C24620N1004.
Is contract 36C24620N1004 an order under another contract?
Yes. 36C24620N1004 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24620N1004 competed?
The extent of competition for 36C24620N1004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award